Mr. Lee’s representative experience includes:
- Quanta Dialysis Technologies on multiple private funding rounds including its most recent $245 million oversubscribed Series D funding round, the largest private funding round for a dialysis device company in history.
- Achilles Therapeutics plc on its Initial Public Offering on NASDAQ with total proceeds of $175.5 million. Achilles is a biopharmaceutical company developing personalised cancer immunotherapies.
- Achilles Therapeutics on the completion of its £52.7 million Series C.
- COMPASS Pathways plc on its public follow-on offering on NASDAQ of American Depositary Shares for gross proceeds of approximately $144 million.
- COMPASS Pathways plc on its $146.6 million initial public offering on NASDAQ. Compass is a life sciences company dedicated to accelerating patient access to evidence based innovation in mental health.
- Rockend Limited, a company aiming to create novel cell therapeutics on its seed financing and subsequent seed extension financing.
- Wintermute Trading Limited, a leading global crypto market maker, on their $20 million Series B funding round.
- Wintermute Trading Limited on its $2.8 million Series A financing.